Evidence map›Paper›PMID 37597120›Full record

ArticlePediatric cardiology2023

Autosomal Recessive Long QT Syndrome: Clinical Aspects and Therapy.

Daniela Righi, Luigina Porco, Corrado Di Mambro, Maria Gnazzo, Anwar Baban, Simone Paglia, Massimo Stefano Silvetti, Antonio Novelli, Alberto Eugenio Tozzi, Fabrizio Drago

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Daniela RighiCardiac Arrhythmias Complex Unit, Department of Pediatric Cardiology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. daniela.righi@opbg.net.ORCID http://orcid.org/0000-0002-9118-4022
Luigina PorcoCardiac Arrhythmias Complex Unit, Department of Pediatric Cardiology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Corrado Di MambroCardiac Arrhythmias Complex Unit, Department of Pediatric Cardiology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Maria GnazzoLaboratory of Medical Genetics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Anwar BabanCardiac Arrhythmias Complex Unit, Department of Pediatric Cardiology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Simone PagliaCardiac Arrhythmias Complex Unit, Department of Pediatric Cardiology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Massimo Stefano SilvettiCardiac Arrhythmias Complex Unit, Department of Pediatric Cardiology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Antonio NovelliLaboratory of Medical Genetics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Alberto Eugenio TozziPredictive and Preventive Medicine Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Fabrizio DragoCardiac Arrhythmias Complex Unit, Department of Pediatric Cardiology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Bambino Gesù Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The autosomal recessive (AR) form of Long QT Syndrome (LQTS) is described both associated with deafness known as Jervell and Lange-Nielsen (JLN) syndrome, and without deafness (WD). The aim of the study is to report the characteristics of AR LQTS patients and the efficacy of the therapy. Data of all children with AR LQTS referred to the Bambino Gesù Children's Hospital IRCCS from September 2012 to September 2021were included. Three (30%) patients had compound heterozygosity and 7 (70%) had homozygous variants of the KCNQ1 gene, the latter showing deafness. Four patients (40%) presented aborted sudden cardiac death (aSCD): three with previous episodes of syncope (75%), the other without previous symptoms (16.6% of asymptomatic patients). An episode of aSCD occurred in 2/3 (66.7%) of WD and heterozygous patients, while in 2/7 (28%) JLN and homozygous patients and in 2/2 patients with QTC > 600 ms. All patients were treated with Nadolol. In 5 Mexiletine was added, shortening QTc and obtaining the disappearance of the T-wave alternance (TWA) in 3/3. Episodes of aSCD seem to be more frequent in LQTS patients with compound heterozygous variants and WD than in those with JLN and homozygous variants. Episodes of aSCD also appear more frequent in children with syncope or with QTc value > 600 ms, even on beta-blocker therapy, than in patients without syncope or with Qtc < 600 ms. However, our descriptive results should be confirmed by larger studies. Moreover, Mexiletine addition reduced QTc value and eliminated TWA.

Indexed as

DeafnessHeart ArrestJervell-Lange Nielsen SyndromeLong QT SyndromeChildHumansKCNQ1 Potassium ChannelMexiletineSyncopeKCNQ1 Potassium ChannelMexiletineAborted sudden cardiac deathJerwell and Lange-Nielsen syndromeLong QT syndromeMexiletineRecessive form

Identifiers

PMID37597120
OpenAlexW4386000160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.